Response to antiretroviral therapy in HIV - infected patients attending care and treatment centre in Dar-es-salaam, Tanzania

dc.contributor.authorMtesigwa, Peter Benard
dc.date.accessioned2015-05-12T12:46:16Z
dc.date.available2015-05-12T12:46:16Z
dc.date.issued2013
dc.description.abstractAccess to antiretroviral therapy and Human immunodeficiency virus (HIV) care is increasing in resource-limited settings like Tanzania. This study was conducted to evaluate prevalence and risk factors associated with treatment failure, in HIV patient on Anti Retroviral Therapy (ART) for more than six months in Dar es Salaam. A cross-sectional observational study that involved 70 conveniently sampled and consented HIV-infected patients who were on antiretroviral therapy for more than six month at PASADA Care and Treatment Centre (CTC) in Dar es Salaam. The findings of this study indicated that majority of Patient 78.5% (n=55) were experiencing ARVs benefits, they attained total viral suppression (<400 viral copies/ml. Ten percent (n=7) of patients were reported to have virological failure suppression (>10,000 viral copies/ml), and 10.4% (n=8) of them found to have partially viral suppression (400-9999 viral copies/ml). On the other hand, 27.1% (n=19) of participants were reported to have an immunological failure. Poor adherence to the treatment regime and drug toxicity were the main factors observed to associate with treatment failure in this study (P<0.05). Although many HIV-infected patients attending CTC in Dar es Salaam had advanced HIV infection, the majority of patients who were receiving antiretroviral therapy were experiencing viral suppression and clinical benefit. In order to optimize the likelihood of viral suppression and prolong benefits of improved quality of life to those HIV patients on ART attending CTC, early HIV testing, initiation of therapy with a potent, durable regimen, accompanied by stable drug supplies and proper counselling on drug adherence are important. Furthermore prospective studies on treatment failures, factors associating with treatment failures and studies that will aim at developing low-cost molecular methods to identify virological failure and ARV sensitivity were urgently needed.en_US
dc.description.sponsorshipWelcome Trust through SACIDS.en_US
dc.identifier.urihttps://www.suaire.sua.ac.tz/handle/123456789/589
dc.language.isoenen_US
dc.language.isoenen_US
dc.language.isoenen_US
dc.language.isoenen_US
dc.publisherSokoine University of Agricultureen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectHiv- infected patientsen_US
dc.subjectAttending careen_US
dc.subjectTreatment centreen_US
dc.subjectDar-es-salaamen_US
dc.subjectTanzaniaen_US
dc.titleResponse to antiretroviral therapy in HIV - infected patients attending care and treatment centre in Dar-es-salaam, Tanzaniaen_US
dc.typeThesisen_US
dc.typeThesisen_US
dc.typeThesisen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PETER BENARD MTESIGWA.pdf
Size:
626.26 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: